Celsius' (CELH) Hold (C-) Rating Reaffirmed at Weiss Ratings

Key Points

• Celsius' stock has a "hold (C-)" rating reaffirmed by Weiss Ratings, with a consensus rating of "Moderate Buy" and a price target of $63.15.
• Investment firms have varied opinions on Celsius, with Piper Sandler increasing their price target to $69.00 and Bank of America raising theirs to $55.00, while Zacks Research downgraded the stock to "hold".
• Insider sales of Celsius stock included a major transaction by CEO John Fieldly, who sold 143,167 shares at an average price of $51.18, reflecting a 13.78% decrease in their holdings.

Celsius (NASDAQ:CELH - Get Free Report)'s stock had its "hold (c-)" rating reiterated by investment analysts at Weiss Ratings in a research note issued on Tuesday,Weiss Ratings reports.

A number of other brokerages also recently issued reports on CELH. Piper Sandler increased their price target on Celsius from $60.00 to $69.00 and gave the stock an "overweight" rating in a research report on Monday, September 8th. Morgan Stanley set a $70.00 price target on Celsius in a research report on Tuesday, September 30th. Truist Financial increased their price target on Celsius from $65.00 to $70.00 and gave the stock a "buy" rating in a research report on Monday, September 8th. Zacks Research downgraded Celsius from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 6th. Finally, Bank of America increased their price target on Celsius from $40.00 to $55.00 and gave the stock an "underperform" rating in a research report on Wednesday, October 8th. Nineteen investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Celsius has a consensus rating of "Moderate Buy" and a consensus price target of $63.15.

Celsius Stock Performance

Shares of NASDAQ CELH traded up $1.43 during trading hours on Tuesday, reaching $62.57. 1,617,872 shares of the stock were exchanged, compared to its average volume of 7,692,824. The firm has a market capitalization of $16.14 billion, a price-to-earnings ratio of 168.93, a P/E/G ratio of 1.22 and a beta of 1.38. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. Celsius has a 52 week low of $21.10 and a 52 week high of $64.81. The stock's fifty day simple moving average is $57.21 and its 200 day simple moving average is $46.24.

Celsius (NASDAQ:CELH - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. The company had revenue of $739.30 million for the quarter, compared to analyst estimates of $632.13 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The firm's quarterly revenue was up 83.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.28 earnings per share. Sell-side analysts predict that Celsius will post 0.89 EPS for the current year.

Insider Buying and Selling

In related news, insider Paul H. Storey sold 7,500 shares of the firm's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $60.93, for a total transaction of $456,975.00. Following the sale, the insider owned 37,550 shares of the company's stock, valued at $2,287,921.50. This trade represents a 16.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO John Fieldly sold 143,167 shares of the firm's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $51.18, for a total value of $7,327,287.06. Following the sale, the chief executive officer directly owned 895,410 shares in the company, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 560,667 shares of company stock worth $27,240,162. 2.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Celsius

Several hedge funds have recently modified their holdings of the company. ProShare Advisors LLC boosted its holdings in shares of Celsius by 3.9% during the 2nd quarter. ProShare Advisors LLC now owns 6,970 shares of the company's stock valued at $323,000 after acquiring an additional 261 shares in the last quarter. Blue Chip Partners LLC boosted its holdings in shares of Celsius by 2.4% during the 2nd quarter. Blue Chip Partners LLC now owns 11,701 shares of the company's stock valued at $543,000 after acquiring an additional 271 shares in the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Celsius by 1.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 18,221 shares of the company's stock valued at $845,000 after acquiring an additional 279 shares in the last quarter. Spire Wealth Management boosted its holdings in shares of Celsius by 12.0% during the 1st quarter. Spire Wealth Management now owns 2,677 shares of the company's stock valued at $95,000 after acquiring an additional 287 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its holdings in shares of Celsius by 8.8% during the 1st quarter. TD Private Client Wealth LLC now owns 4,071 shares of the company's stock valued at $145,000 after acquiring an additional 328 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company's stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.